Skip to main content
. 2020 Sep 29;203(1):105–114. doi: 10.1111/cei.13511

Table 2.

Variants and genotypes of patients with uncertain significance genotype (n = 35)

ID patients Gene mutation c. mutation p. rs ID MAF (GnomAD) Zygosity Interpretation
Sanger strategy
9 NLRP3 c.592G>A p.(Val198Met) rs121908147 0.008460 Heterozygous VUS
70 NLRP3 c.592G>A p.(Val198Met) rs121908147 0.008460 Heterozygous VUS
81 TNFRSF1A c.362G>A p.(Arg121Gln) rs4149584 0.01290 Heterozygous VUS
109 ADA2 c.139G>A p.(Gly47Arg) rs202134424 2.437e‐5 Heterozygous HTZ‐MAR
113 MEFV c.2230G>T p.(Ala744Ser) rs61732874 0.001753 Heterozygous HTZ‐MAR
121 NOD2 c.1177C>T p.(Arg393Cys) rs140716236 0.0001479 Heterozygous VUS
122 TNFRSF1A c.362G>A p.(Arg121Gln) rs4149584 0.01290 Heterozygous VUS
127 MEFV c.1772T>C p.(Ile591Thr) rs11466045 0.01082 Heterozygous VUS
136 NOD2 c.2883‐2A>G SAV rs564226539 2.442e‐5 Heterozygous VUS
164 MEFV c.2080A>G p.(Met694Val) rs61752717 0.0002669 Heterozygous HTZ‐MAR
206 MEFV c.1772T>C p.(Ile591Thr) rs11466045 0.01082 Heterozygous VUS
232 MEFV c.2084A>G p.(Lys695Arg) rs104895094 0.005894 Heterozygous HTZ‐MAR
NLRP3 c.2107C>A p.(Gln703Lys) rs35829419 0.03861 Heterozygous VUS
233 MEFV c.2084A>G p.(Lys695Arg) rs104895094 0.005894 Heterozygous HTZ‐MAR
237 MEFV c.2080A>G p.(Met694Val) rs61752717 0.0002669 Heterozygous HTZ‐MAR
275 MEFV c.2080A>G p.(Met694Val) rs61752717 0.0002669 Heterozygous HTZ‐MAR
NGS strategy
5 MEFV c.1105C>T p.(Pro369Ser) rs11466023 0.01471 Heterozygous VUS
19 NLRP3 c.592G>A p.(Val198Met) rs121908147 0.008460 Heterozygous VUS
31 IL10RA c.883C>T p.(Pro295Ser) rs201777547 0.0001912 Heterozygous HTZ‐MAR
99 NLRP3 c.592G>A p.(Val198Met) rs121908147 0.008460 Heterozygous VUS
105 AP1S3 c.318T>A p.(Asn106Lys) n.a. n.a. Heterozygous VUS
NOD2 c.2507T>C p.(Ile836Thr) rs763192145 4.062e‐5 Heterozygous VUS
113 TNFRSF1A c.362G>A p.(Arg121Gln) rs4149584 0.01290 Heterozygous VUS
129 NLRP3 c.404G>A p.(Arg135His) n.a. n.a. Heterozygous VUS
133 MEFV c.442G>C p.(Glu148Gln) rs3743930 0.06564 Heterozygous VUS
NLRP3 c.2107C>A p.(Gln703Lys) rs35829419 0.03861 Heterozygous VUS
135 MEFV c.442G>C p.(Glu148Gln) rs3743930 0.06564 Heterozygous VUS
MEFV c.1105C>T p.(Pro369Ser) rs11466023 0.01471 Heterozygous VUS
138 NOD2 c.2883‐2A>G SAV rs564226539 2.442e‐5 Heterozygous VUS
139 NLRP3 c.1556T>C p.(Ile519Thr) n.a. n.a. Heterozygous VUS
151 NOD2 c.2050C>T p.(Arg684Trp) rs5743276 0.0003952 Heterozygous VUS
NOD2 c.2722G>C p.(Gly908Arg) rs2066845 0.01085 Heterozygous VUS
NOD2 c.3056G>T p.(Arg1019Leu) rs5743295) 3.972e‐5 Heterozygous VUS
IL10RA c.698T>G p.(Val233Gly) rs138929400 0.001378 Heterozygous HTZ‐MAR
183 CARD14 c.2870_2872delAGG p.(Glu957del) n.a. 3.23e‐5 Heterozygous VUS
187 PSTPIP1 c.203C>T p.(Thr68Met) rs201872851 0.001518 Heterozygous VUS
225 PSTPIP1 c.1213C>T p.(Arg405Cys) rs201253322 0.0005487 Heterozygous VUS
231 ADAR c.3401A>G p.(Tyr1134Cys) rs150284449 9.74e‐5 Heterozygous HTZ‐MAR
MEFV c.442G>C p.(Glu148Gln) rs3743930 0.06564 Heterozygous VUS
PSTPIP1 c.1213C>T p.(Arg405Cys) rs201253322 0.0005487 Heterozygous VUS
232 NLRP3 c.2107C>A p.(Gln703Lys) rs35829419 0.03861 Heterozygous VUS
TNFRSF1A c.362G>A p.(Arg121Gln) rs4149584 0.01290 Heterozygous VUS
235 MEFV c.442G>C p.(Glu148Gln) rs3743930 0.06564 Heterozygous VUS
NLRP12 c.1054C>T p.(Arg352Cys) rs199881207 0.0003863 Heterozygous VUS
236 MEFV c.2080A>G p.(Met694Val) rs61752717 0.0002669 Heterozygous HTZ‐MAR
241 RNASEH2B c.529G>A p.(Ala177Thr) rs75184679 0.001361 Heterozygous HTZ‐MAR

HTZ‐MAR = heterozygous mutation associated with autosomal recessive disorders; SAV = splice acceptor variant; n.a. = not available; VUS = variants of uncertain significance.